Lilly says retatrutide beat Ozempic on weight loss and blood sugar in head-to-head trial
Participants on the 12 mg dose lost an average of 47.4 pounds over 80 weeks, against 20.9 pounds for those on Ozempic. More people on retatrutide stopped treatment early due to side effects, and the results have not yet been peer-reviewed.
2 min read